Research

Mixed

Genetic polymorphisms in PNPLA3 (rs738409) and TM6SF2 (rs58542926) are associated with an increased risk of advanced fibrosis in NAFLD patients, independent of metabolic variables.

If you have a family history of fatty liver or known genetic variants like PNPLA3, you may be at higher risk for fibrosis. This means you should be more vigilant about managing metabolic health (weight, diabetes, blood pressure) as these factors interact with your genetics to drive progression.

GoodSupportsHIGH confidence
One study of over 1000 individuals with biopsy proven NAFLD, demonstrated these SNPs were associated with a 40% to 88% increased risk for advanced (F2-4) fibrosis after adjustment for age, sex, and metabolic variables.
Luis Calzadilla Bertot et al. · International Journal of Molecular Sciences · 2016

Why this rating

Based on genome-wide association studies and large cohort studies.

Source

The Natural Course of Non-Alcoholic Fatty Liver Disease

Luis Calzadilla Bertot et al. · International Journal of Molecular Sciences · 2016

DOI 10.3390/ijms17050774

narrative_reviewCited 625×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →